Advanced Search


Study ID Status Title Patient Level Data
205732 Not yet recruiting An open-label, randomised, single-dose, two-period cross-over study to evaluate bioequivalence of SKF101804 cefixime 400 mg capsule versus cefixime 400 mg capsule reference product in healthy adult participants under fasting conditions
205744 Recruiting A phase I/II, open-label, 2 arm study to investigate the safety, clinical activity, pharmacokinetics and pharmacodynamics of GSK2879552 administered alone or in combination with azacitidine, in adult subjects with IPSS-R high and very high risk myelodysplastic syndromes (MDS) previously treated with hypomethylating agents (HMA)
205756 Not yet recruiting A single arm, open label, clinical study of cryopreserved autologous CD34+ cells transduced with lentiviral vector containing human ARSA cDNA (GSK2696274), for the treatment of early onset Metachromatic Leukodystrophy (MLD)
205759 Completed A single center, double-blind, randomized, placebo-controlled, parallel, single and repeat, dose-ascending study to evaluate the safety, tolerability and pharmacokinetics of GSK2269557 administered via the ELLIPTA™ dry powder inhaler to healthy Japanese subjects
205787 Completed Assessment of Patients Treated with Albiglutide - Phase 1
205794 Completed A Study to Evaluate the Efficacy of an Experimental Occlusion Technology Dentifrice in the Relief of Dentinal Hypersensitivity
205795 Completed Sun Protection Factor Determination (In vivo determination of the sun protection factor ISO 24444:2010(E))
205807 Not yet recruiting Observational Study to describe the Prevalence of Severe Asthma in Spanish Hospitals
205808 Completed A double-blind, randomized, placebo controlled, dose escalating crossover study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in Japanese healthy male volunteers
205813 Not yet recruiting Methodology study to investigate the utility of retroviral insertion site analysis in samples from subjects treated with Strimvelis™ gene therapy
205815 Withdrawn Horlicks Cardia+: investigating the glycaemic index and satiety effect of Horlicks Cardia+
205816 Not yet recruiting Discrete Choice Experiment in Severe Asthma
205820 Completed A Two Part Study to Assess i) the Relative Bioavailability and Food Effect of a Novel Tablet Formulation of Boosted-GSK2838232 Compared to Capsule and ii) the Safety and Pharmacokinetics of Repeated Once-Daily Doses of Non-boosted GSK2838232
205821 Not yet recruiting Study to elucidate the association of the Renin-angiotensin system and right ventricular function in mechanically ventilated patients
205822 Recruiting A double-blind (sponsor unblind), randomized, placebo-controlled, single and repeat escalating dose study to investigate the safety, tolerability, and pharmacokinetics of CCI15106 inhalation powder in healthy participants and participants with moderate chronic obstructive pulmonary disease (COPD) including evaluation of environmental and healthy by-stander exposure levels during dosing
205832 Active, not recruiting A Phase IIb, 24 week, randomized, double-blind, 3 arm parallel group study, comparing the efficacy, safety and tolerability of two doses of umeclidinium bromide administered once-daily via a dry powder inhaler, versus placebo, in participants with asthma
205846 Not yet recruiting PRJ2693: Descriptive Analysis of Neuropsychiatric Diagnoses in Patients taking Dolutegravir in the OPERA® Observational Database
205847 Active, not recruiting Long term immunogenicity up to 15 years after the first booster immunization with GSK Biologicals’ Encepur Adults (Polygeline-free Tick-Borne Encephalitis vaccine for adults) in adults who received 1 of 3 different primary vaccination schedules
205854 Not yet recruiting A Phase IV, randomized, open-label study to evaluate one year long-term persistence of immune responses following two different rabies vaccine post-exposure regimens (Zagreb 2-1-1 and Essen 1-1-1-1-1) in Chinese Children
205862 Completed Claims-linked Survey Study to Assess Patient-reported COPD Symptoms and Burden of Illness among a Prevalent Population
205863 Not yet recruiting COPD Severity and Adherence to GOLD Guidelines in the Community Pharmacy Setting
205864 Recruiting A randomized, double-blind, Sponsor open, placebo-controlled, 52 week study evaluating the effect of danirixin (GSK1325756) on lung function and health related quality of life in participants with mild to moderate Chronic Obstructive Pulmonary Disease (COPD)
205865 Completed Sun Protection Factor Determination: In vivo Determination of the Sun Protection Factor (SPF): ISO 24444:2010(E)
205875 Not yet recruiting A Post-Marketing Observational Study to Evaluate the Safety of Tykerb® in Chinese Patients
205881 Not yet recruiting Evaluation of referring HCPs’ and parents’/carers’ understanding of specific risks associated with Strimvelis™ treatment



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.